Delivery Order SPE2DB24D2100-SPE2DB25FBDGR
Award Date
4/7/25
Potential Completion Date
4/8/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Quillivant XR 25 mg/5 ml suspension, a 60 ml medication. The firm-fixed-price delivery order has a ceiling value of $1,846.75 and an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml bottles. The contract is a delivery order with a firm fixed price of $1,524.36 and a completion date of June 7, 2023. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides medical supplies and pharmaceuticals to military and federal healthcare facilities. AmerisourceBergen holds a substantial...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,187.66, is for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. It is a delivery order contract with a firm fixed price, with a completion date of January 24, 2025. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime contractor, and...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,794.76, is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 22, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,344.65 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication Quillivant XR 25 mg/5 ml suspension in 150 ml bottles. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a vehicle for the company to supply a broad range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,150.71, is for the supply of Quillivant XR 25 mg/5 ml suspension in 180 ml containers. This is a firm fixed-price delivery order contract with a completion date of February 27, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles, with a ceiling value of $1,398.84 and a performance period ending on January 29, 2025. This award is not associated with a set-aside program. AmerisourceBergen also holds a...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 60 ml, to the U.S. government. The $2,592.57 firm fixed-price contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of May 30, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,577.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Quillivant XR, a 25 mg/5 ml suspension medication. The contract is a firm fixed-price arrangement with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.84 Firm Fixed Price Delivery Order is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...